European approval is based on robust Phase III data showing Cosentyx provided rapid symptom relief from as early as Week 4, with response rates continuing to improve up to 1 year1,3-5
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
The award recognizes and supports promising female scientists working in mass spectrometry
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
Subscribe To Our Newsletter & Stay Updated
